Visit (Number) vs Cogscreen Pathfinder Number (PN) Accurarcy
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,105 | 99.3 | ± 5.0 | 100.0 | -9.0 | 100.0 | 411 | 1,516 |
CPAP Titration Visit (CPAP) | - | - | - | - | - | - | 1,516 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 1,105 | 77.7 | ± 42.7 | 100.0 | -7.0 | 100.0 | 411 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 1,105 | 74.9 | ± 44.6 | 100.0 | -9.0 | 100.0 | 411 | 1,516 |
Gender vs Cogscreen Pathfinder Number (PN) Accurarcy
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Accurarcy
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Accurarcy
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 99.3 | ± 5.0 | 100.0 | -9.0 | 100.0 | 411 | 1,516 |
Male | 723 | 99.3 | ± 4.4 | 100.0 | -9.0 | 100.0 | 235 | 958 |
Female | 382 | 99.2 | ± 5.8 | 100.0 | -9.0 | 100.0 | 176 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Accurarcy
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Accurarcy
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 77.7 | ± 42.7 | 100.0 | -7.0 | 100.0 | 411 | 1,516 |
Male | 723 | 77.3 | ± 43.1 | 100.0 | -7.0 | 100.0 | 235 | 958 |
Female | 382 | 78.6 | ± 42.1 | 100.0 | -7.0 | 100.0 | 176 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Accurarcy
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Cogscreen Pathfinder Number (PN) Accurarcy
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 74.9 | ± 44.6 | 100.0 | -9.0 | 100.0 | 411 | 1,516 |
Male | 723 | 74.4 | ± 45.0 | 100.0 | -9.0 | 100.0 | 235 | 958 |
Female | 382 | 75.9 | ± 43.9 | 100.0 | -7.0 | 100.0 | 176 | 558 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Accurarcy
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Accurarcy
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Accurarcy
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 99.3 | ± 5.0 | 100.0 | -9.0 | 100.0 | 411 | 1,516 |
Native American | 18 | 98.8 | ± 2.4 | 100.0 | 91.7 | 100.0 | 10 | 28 |
Asian | 61 | 99.7 | ± 1.2 | 100.0 | 95.8 | 100.0 | 28 | 89 |
Black | 103 | 99.3 | ± 1.9 | 100.0 | 90.5 | 100.0 | 69 | 172 |
Hispanic | 77 | 99.7 | ± 1.1 | 100.0 | 95.8 | 100.0 | 39 | 116 |
White | 841 | 99.2 | ± 5.6 | 100.0 | -9.0 | 100.0 | 261 | 1,102 |
Other | 5 | 100.0 | ± 0.0 | 100.0 | 100.0 | 100.0 | 4 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Accurarcy
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Accurarcy
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 77.7 | ± 42.7 | 100.0 | -7.0 | 100.0 | 411 | 1,516 |
Native American | 18 | 64.4 | ± 50.2 | 97.9 | -6.0 | 100.0 | 10 | 28 |
Asian | 61 | 77.4 | ± 43.5 | 100.0 | -7.0 | 100.0 | 28 | 89 |
Black | 103 | 72.9 | ± 46.1 | 100.0 | -7.0 | 100.0 | 69 | 172 |
Hispanic | 77 | 83.0 | ± 38.5 | 100.0 | -7.0 | 100.0 | 39 | 116 |
White | 841 | 78.3 | ± 42.4 | 100.0 | -7.0 | 100.0 | 261 | 1,102 |
Other | 5 | 57.6 | ± 58.1 | 100.0 | -6.0 | 100.0 | 4 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Accurarcy
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Cogscreen Pathfinder Number (PN) Accurarcy
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,105 | 74.9 | ± 44.6 | 100.0 | -9.0 | 100.0 | 411 | 1,516 |
Native American | 18 | 70.6 | ± 48.9 | 100.0 | -6.0 | 100.0 | 10 | 28 |
Asian | 61 | 80.9 | ± 41.1 | 100.0 | -7.0 | 100.0 | 28 | 89 |
Black | 103 | 70.8 | ± 47.3 | 100.0 | -7.0 | 100.0 | 69 | 172 |
Hispanic | 77 | 77.5 | ± 43.1 | 100.0 | -7.0 | 100.0 | 39 | 116 |
White | 841 | 74.9 | ± 44.6 | 100.0 | -9.0 | 100.0 | 261 | 1,102 |
Other | 5 | 57.6 | ± 58.1 | 100.0 | -6.0 | 100.0 | 4 | 9 |